- Home
- HAS vs MDGL Comparison
HAS vs MDGL Comparison
Compare HAS & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAS | MDGL |
|---|---|---|
| Founded | 1923 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 12.8B |
| IPO Year | 1994 | 2005 |
Fundamental Metrics
Financial Performance| Metric | HAS | MDGL |
|---|---|---|
| Price | $93.20 | $542.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 12 |
| Target Price | $109.73 | ★ $674.45 |
| AVG Volume (30 Days) | ★ 1.2M | 236.3K |
| Earning Date | 05-20-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.98% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.51 | N/A |
| Revenue | ★ $5,365,900,000.00 | $180,133,000.00 |
| Revenue This Year | $5.38 | $58.39 |
| Revenue Next Year | $6.48 | $48.55 |
| P/E Ratio | $36.94 | ★ N/A |
| Revenue Growth | ★ 13.06 | N/A |
| 52 Week Low | $69.50 | $393.61 |
| 52 Week High | $106.98 | $615.00 |
Technical Indicators
Market Signals| Indicator | HAS | MDGL |
|---|---|---|
| Relative Strength Index (RSI) | 48.66 | 55.57 |
| Support Level | $92.09 | $529.02 |
| Resistance Level | $94.35 | $545.13 |
| Average True Range (ATR) | 1.91 | 17.76 |
| MACD | -0.61 | 2.63 |
| Stochastic Oscillator | 9.69 | 78.60 |
Price Performance
Historical ComparisonAbout HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Peppa Pig, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and has since divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022 offers the firm access to around 20 million digital tabletop players.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.